标题
An epigenomic approach to therapy for tamoxifen-resistant breast cancer
作者
关键词
-
出版物
CELL RESEARCH
Volume 24, Issue 7, Pages 809-819
出版商
Springer Nature
发表日期
2014-05-30
DOI
10.1038/cr.2014.71
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
- (2015) Harald Herrmann et al. Oncotarget
- Demethylation demystification
- (2013) L. Suarez et al. BLOOD
- Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
- (2013) Floris H. Groenendijk et al. BREAST CANCER RESEARCH AND TREATMENT
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition
- (2013) Naoyuki Sarai et al. EMBO JOURNAL
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- (2012) C. J. Ott et al. BLOOD
- Minireview: Nuclear Receptor and Coregulator Proteomics—2012 and Beyond
- (2012) Bert W. O'Malley et al. MOLECULAR ENDOCRINOLOGY
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Analysis of the Human Endogenous Coregulator Complexome
- (2011) Anna Malovannaya et al. CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors
- (2011) H. R. Hudlebusch et al. CLINICAL CANCER RESEARCH
- NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
- (2011) Alex J. Kuo et al. MOLECULAR CELL
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites
- (2011) Huadong Pei et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
- (2011) J. D. Kessler et al. SCIENCE
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Growth factor stimulation induces a distinct ER cistrome underlying breast cancer endocrine resistance
- (2010) M. Lupien et al. GENES & DEVELOPMENT
- MMSET is overexpressed in cancers: Link with tumor aggressiveness
- (2009) Alboukadel Kassambara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf–Hirschhorn syndrome
- (2009) Keisuke Nimura et al. NATURE
- Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma
- (2009) Don L. Gibbons et al. PLoS One
- The Bromodomain Protein Brd4 Stimulates G1Gene Transcription and Promotes Progression to S Phase
- (2008) Kazuki Mochizuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started